Feedback / Questions
PLT012 - Elixiron Immunotherap
https://www.businesswire.com/news/home/20250429248765/en/Pilatus-Biosciences-Publishes-Preclinical-Data-in-Cancer-Discovery-on-PLT012-First-in-Class-CD36-Targeting-Antibody-for-Liver-Cancer
Apr 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next